CPH
CLB icon

C Partners Holding’s Core Laboratories CLB Stock Holding History

C Partners Holding’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-49,222
Closed -$998K – 18
2022
Q4 		$998K Hold
49,222
– – 0.2% 18
2022
Q3 		$664K Buy
+49,222
New +$829K 0.14% 18
2022
Q2 		– Sell
-733,357
Closed -$23.2M – 19
2022
Q1 		$23.2M Buy
733,357
+421,090
+135% +$11.8M 4% 11
2021
Q4 		$6.97M Buy
+312,267
New +$8.14M 1.28% 17
2021
Q1 		– Sell
-471,952
Closed -$12.5M – 22
2020
Q4 		$12.5M Sell
471,952
-91,072
-16% -$1.86M 3.05% 14
2020
Q3 		$8.59M Sell
563,024
-28,841
-5% -$605K 1.99% 16
2020
Q2 		$12M Sell
591,865
-226,251
-28% -$4.06M 3.3% 13
2020
Q1 		$8.46M Buy
818,116
+534,354
+188% +$14.9M 2.16% 15
2019
Q4 		$10.7M Buy
+283,762
New +$12.7M 3.19% 11
2018
Q4 		– Sell
-1,050
Closed -$122K – 60
2018
Q3 		$122K Sell
1,050
-746
-42% -$84.2K 0.04% 124
2018
Q2 		$227K Sell
1,796
-153
-8% -$18.6K 0.08% 135
2018
Q1 		$211K Sell
1,949
-678
-26% -$75K 0.09% 151
2017
Q4 		$288K Buy
+2,627
New +$262K 0.12% 70

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

C Partners Holding's CLB Position: Q1 2023 in Review

C Partners Holding sold out of Core Laboratories (CLB) in Q1 2023, closing a stake of 49,222 shares — an estimated $998K sold.

C Partners Holding first reported a position in CLB in Q4 2017 and held it in 13 quarters. The position peaked at $23.2M in Q1 2022. 163 funds tracked by Wall St. Rank hold CLB as of Q1 2023.

  • C Partners Holding reported no remaining Core Laboratories position as of Q1 2023 after selling out during the quarter.
  • C Partners Holding sold 49,222 Core Laboratories shares in Q1 2023, an estimated $998K.
  • C Partners Holding first reported a position in Core Laboratories in Q4 2017 and held it in 13 quarters.
  • C Partners Holding's Core Laboratories position peaked at $23.2M in Q1 2022.
  • 163 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2023.

Based on C Partners Holding's 13F filing for Q1 2023, filed 15 May 2023.